CLEVELAND, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST ) (the “Company” or “Innovest”), a Conglomerate with operations in commercial and industrial products and services, and biotechnology, sold its most recent six-figure revenue contract last week, and notes that its Call Center is now generating double the baseline revenue it was generating just a few months ago, when it was acquired. The division is now pacing $4.5 million in annual revenue.
“Sally Emch, our President of Call Center Operations, has doubled the center’s baseline revenue since the acquisition, and the Shepherd team just closed another six figure sale at the end of last week,” said Dan Martin, CEO of Innovest. “The StemVax patent approval has been a recent focus of excitement, and our C&I Group is also really hitting stride. Working together well, closing big competitive sales, and excited to push through the quarter with momentum. The team is so excited at the support our shareholders have shown, and the enthusiasm is something I wish everyone could see.”
The Company maintains an unchanged free-trading float of 11,796,710 common shares with no convertible debts, no warrants or options outstanding. After several days of gains including a high of $.3175, the stock price pulled back 7.93% on Friday to close at $0.27, up 28.5% since the $0.21 open price last Monday, and up over 1,000% on the year.
The Innovest C&I Division is diligently refining organic growth strategies. “Innovest is in discussions with meaningful acquisition targets, but those transactions only work long-term if we can grow them and help them succeed – and so far I couldn’t be more impressed with Division President Damon Mintz, Sally Emch, Bill Oler, Dennis Giancola and the rest of our 40 people who are doing an incredible job right now,” said Mr. Martin. His comments are echoed by the Innovest mission statement, which is, “To operate our business responsibly on a daily basis to maximize shareholder value and be a source of strength to our companies, helping them reach their fullest potential.”
About Innovest Global, Inc. Innovest Global, Inc. (OTC Markets: IVST ) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.
For more information, please visit: http://www.innovestglobal.com , and follow us on Twitter and Facebook @innovestglobal .
Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact Information Corporate Office: (216) 815-1122 info@innovestglobal.com Twitter @innovestglobal
Investor Relations: Hayden IR (917) 658-7878 hart@haydenir.com
